Showing results (161-170 of 1,916) with videos related to
Sort By:
Pageof 192
Current Drug Metabolism|January 29, 2008
Cholinesterase reactivators: the fate and effects in the organism poisoned with organophosphates/nerve agentsJ Bajgar, K Kuca, D Jun, et al.Current Drug Metabolism|January 29, 2008
Quantitative correlations among CYP3A sensitive substrates and inhibitors: literature analysisIsabelle Ragueneau-Majlessi, Xavier Boulenc, Clemence Rauch, et al.Current Drug Metabolism|January 29, 2008
Strategies to in vitro assessment of major human CYP enzyme activities by using liquid chromatography tandem mass spectrometryA Lahoz, M T Donato, J V Castell, et al.Current Drug Metabolism|January 29, 2008
The prediction of the hepatic clearance of tanshinone IIA in rat liver subcellular fractions: accuracy improvementPeng Li, Guang-Ji Wang, Jing Li, et al.Current Drug Metabolism|January 29, 2008
Metabolic pathways of T-2 toxinVlastimil Dohnal, Alena Jezkova, Daniel Jun, et al.Current Drug Metabolism|March 25, 2014
Design and applications of bioprecursors: a retrometabolic approachSuneela Dhaneshwar, Astha Jain, Kunal TewariCurrent Drug Metabolism|February 24, 2017
Challenges in Dermal Delivery of Therapeutic Antimicrobial Protein and PeptidesRohan Lalani, Ambikanandan Misra, Jitendra Amrutiya, et al.Current Drug Metabolism|February 24, 2017
Transdermal Drug Delivery: Opportunities and Challenges for Controlled Delivery of Therapeutic Agents Using NanocarriersBalak Das Kurmi, Pawan Tekchandani, Rishi Paliwal, et al.Current Drug Metabolism|February 24, 2017
Antioxidant Nanoplatforms for Dermal Delivery: MelatoninAroha Sanchez Milan, Ana Cristina Calpena Campmany, Beatriz Clares NaverosCurrent Drug Metabolism|October 20, 2018
Effects of Gut Microbiota on Drug Metabolism and Guidance for Rational Drug Use Under Hypoxic Conditions at High AltitudesJuanhong Zhang, Junmin Zhang, Rong Wang, et al.Pageof 192